EarlySight is an EPFL spin-off founded by a team of 4 with backgrounds in Optoelectronics, Ophthalmology, and Microengineering. Their research project that started in 2016 at co-founder Prof. Moser’s EPFL lab has developed into a machine called Cellularis. It combines lateral illumination of the eye with adaptive optics, a method commonly used in astronomy to provide incredibly detailed pictures of the retina. With a single-cell resolution, this non-invasive approach is much more precise than the alternatives in detecting early signs of disease. The machine has already been shown to very clearly detect macular degenerescence at the single-cell level.
Employees: 11-50
Total raised: $2.56M
Founded date: 2019
Investors 5
| Date | Name | Website |
| - | Verve Vent... | verve.vc |
| - | Venture Ki... | venturekic... |
| - | MassChalle... | masschalle... |
| 09.11.2022 | VentureLab | venturelab... |
| - | NovaCapita... | novacapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.05.2021 | - | $2.56M | - |
Mentions in press and media 16
| Date | Title | Description |
| 06.06.2024 | Innosuisse recognizes startups envisioned to transform the medical sector | Startups that apply for the Innosuisse Certificate after completing the Innosuisse Core Coaching program undergo a comprehensive evaluation of their innovation capabilities, financial readiness for external funding, and management structur... |
| 27.10.2023 | Quatre startups de Genève récompensées par le FIF | |
| 01.04.2022 | Venture Leaders Medtech 2022: 10 innovative startups will advance their global growth in Boston | |
| 16.12.2021 | IMD 37 Startup Competition 2022 Winners announced | |
| 27.05.2021 | EarlySight raises CHF 2.3 million to detect and treat retinal diseases | The funds will allow EarlySight to grow the team, optimize its technology and perform additional clinical validations. Thanks to them, important milestones will be reached to prepare the company for market entry. Timothé Laforest, CEO and c... |
| 26.05.2021 | EarlySight banks 2.3 million seed investment | |
| 26.05.2021 | EarlySight banks 2.3 million seed investment | Founded in 2019, EarlySight uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina. Its technology combines hardware and software to propose a unique medical device that can observe the cells ... |
| 26.05.2021 | Geneva-based EarlySight lands €2 million for its eye diseases diagnostic tool | Today EarlySight, an EPFL spin-off developing the next generation of eye diseases diagnostic tool, has announced the first closing of around €2 million, in its approx. €2.7 million seed funding round. The startup, which was founded in March... |
| 20.04.2021 | Swiss Medtech Award shortlist revealed | The Swiss Medtech Award recognises the most outstanding medical technologies in Switzerland. For the 23rd edition, the jury has selected six companies that will proceed to the next stage to compete for one of the three spots in the final ro... |
| 20.04.2021 | Swiss Medtech Award shortlist revealed |
Show more